RESOURCES


home.aspx
   
Is the opioid crisis mainly a story of ‘late capitalism’ or something more complicated? IS THE OPIOID CRISIS MAINLY A STORY OF ‘LATE CAPITALISM’ OR SOMETHING MORE COMPLICATED?

article

Dec 02, 2019

For capitalism’s critics, the opioid crisis is a powerful witness for the prosecution. They charge that inequality, stagnant wages, immobility, job loss — the four horsemen of the neoliberalism endgame — have generated a massive surge in “deaths of despair,” especially ...

Read More

How AI is Shaping the Future of the Pharmaceutical Industry HOW AI IS SHAPING THE FUTURE OF THE PHARMACEUTICAL INDUSTRY

article

Dec 02, 2019

Artificial Intelligence and Machine Learning are powering incredible changes across a huge range of industries. But in data and research-dependent industries such as pharmaceuticals, they’re having an unparalleled impact. From improving candidate selection processes for clinical trials, to acc...

Read More

Could AI create a brave new world of pharma R&D? COULD AI CREATE A BRAVE NEW WORLD OF PHARMA R&D?

article

Nov 29, 2019

Barely a week goes by without one big pharma or biotech announcing that it is using AI to develop new medicines. Richard Staines looks at the progress already made thanks to this potentially revolutionary technology, and how it could change the fortunes of a beleaguered pharma industry. Artificial I...

Read More

Silos in Pharma – The Data Issue SILOS IN PHARMA – THE DATA ISSUE

article

Nov 28, 2019

A key component of product innovation in the pharmaceutical industry is the analysis of data. Yet, the Pharma industry can be diagnosed as suffering with one particular problem: the prevalence of data silos. Often stored across disparate tools and locations, the isolation of data severely impacts th...

Read More

Modern pharma grows more colourful MODERN PHARMA GROWS MORE COLOURFUL

article

Nov 28, 2019

The modern pharmacy retail segment is welcoming an exciting new entrant in Japanese drug and cosmetics retailer Matsumotokiyoshi Co., Ltd, urging existing players to dust down their racing goggles. Matsumotokiyoshi has agreed to form a joint venture with Lotus Food Group JSC to operate a drugstore c...

Read More

A safer ride: the latest innovation in targeted cancer treatment A SAFER RIDE: THE LATEST INNOVATION IN TARGETED CANCER TREATMENT

article

Nov 28, 2019

One downside of the antibody-drug conjugates used in oncology today is that the drug-carrying antibodies can shed much of their toxic cargo on the way to the tumour site. Now, German researchers have published their method for attaching drugs to antibodies with greater stability, potentially making ...

Read More

Where the Nurse Prescribes Heroin WHERE THE NURSE PRESCRIBES HEROIN

article

Nov 27, 2019

A new program in Glasgow will give drug users pharmaceutical-grade heroin twice daily in a bid to reduce drug-related deaths. Homeless drug users in Scotland will be allowed to inject pharmaceutical-grade heroin twice a day under the supervision of medical officials as part of a new program intended...

Read More

How does CBD affect your memory? HOW DOES CBD AFFECT YOUR MEMORY?

article

Nov 27, 2019

One of the great benefits of smoking marijuana is that there’s rarely any hangovers on the following day. Sadly, the plant still has the capability of rattling your memories. Cannabis, or THC more precisely, tends to affect people’s cognitive function and short term memory skills, which ...

Read More

Pharmaceutical Industry Is Adopting AI On Numerous Fronts PHARMACEUTICAL INDUSTRY IS ADOPTING AI ON NUMEROUS FRONTS

article

Nov 25, 2019

The pharmaceutical industry is adopting artificial intelligence (AI) on numerous fronts, from discovery and clinical development to risk assessment and safety monitoring, regulatory, and manufacturing. Pharmaceutical and biotechnology companies, as well as service providers now, rely on AI technolog...

Read More

4 Common Misconceptions About Cold Chain Logistics 4 COMMON MISCONCEPTIONS ABOUT COLD CHAIN LOGISTICS

article

Nov 22, 2019

When it comes to shipping pharmaceuticals, we use cold chain materials to control the temperature of your drugs or medicines from the manufacturer through a delivery to the end user. It’s critical to keep these within the proper temperature range because they can be rendered useless or even ha...

Read More

Pharma Cold chain tracking : a prototype PHARMA COLD CHAIN TRACKING : A PROTOTYPE

article

Nov 22, 2019

Innovation with the Internet of Things(IoT) has been an on-going effort. Although IoT appeared in the Gartner hype cycle for 2017, it has been around for a very long time and businesses have experimented with this technology since the time we can remember. It’s only in the recent past that cos...

Read More

Are medtech companies ready for the robotics digital data revolution? ARE MEDTECH COMPANIES READY FOR THE ROBOTICS DIGITAL DATA REVOLUTION?

article

Nov 22, 2019

The ultimate value that robotics data will provide is in improving outcomes through better recording of process, approach, measurements and outcomes data. Collected through an individual robot in one OR, that data is likely interesting, but not significantly valuable. It’s also not linked to t...

Read More

Digital Transformation: A Guide for Pharma Marketers DIGITAL TRANSFORMATION: A GUIDE FOR PHARMA MARKETERS

article

Nov 21, 2019

Artificial intelligence (AI) and machine learning (ML) are not yet perfect sciences, but they are transforming life sciences companies in practical and meaningful ways. This includes improving targeting and relationships with healthcare providers (HCPs) and patients. However, organizations need to b...

Read More

5 Things a Landlord Should Know About Recreational Cannabis in Illinois 5 THINGS A LANDLORD SHOULD KNOW ABOUT RECREATIONAL CANNABIS IN ILLINOIS

article

Nov 21, 2019

Registered qualifying patients under the Compassionate Use of Medical Cannabis Pilot Program Act, are granted certain exceptions for possession volume and cultivation of cannabis. Further, the CRTA does not permit any person to smoke cannabis in any place where smoking is already prohibited under th...

Read More

What to know about cannabis advertising in 2020 WHAT TO KNOW ABOUT CANNABIS ADVERTISING IN 2020

article

Nov 21, 2019

If you are a business owner you might know advertising can be challenging at times, especially if you are an owner of a Cannabis Dispensary or CBD Shop. You are not sure where to start. You might ask yourself do I need someone to help me with this? What are the laws, rules and regulations for advert...

Read More

Coughs and sneezes spread diseases: charting the development of flu vaccines COUGHS AND SNEEZES SPREAD DISEASES: CHARTING THE DEVELOPMENT OF FLU VACCINES

article

Nov 21, 2019

Vaccines have been established as the most effective method of preventing flu since the early 20th century, however, much has changed in the past century to improve effectiveness, administration and adherence in the face of flu viruses’ constant mutation. Allie Nawrat charts the development of...

Read More

Pharma Cyber Security: How to Tackle Malware Threats PHARMA CYBER SECURITY: HOW TO TACKLE MALWARE THREATS

article

Nov 20, 2019

The global pharmaceutical market is expected to grow to almost 1.2 billion by 2021,1 thanks in part to rapid advancements in digital automation and innovation. Unfortunately, these growth-generating strategies also open pharma manufacturers up to new risks. For example, acquisitions and outsourcing ...

Read More

Searching Chemical Spaces to Boost Drug Development SEARCHING CHEMICAL SPACES TO BOOST DRUG DEVELOPMENT

article

Nov 20, 2019

In drug discoverers’ jargon, large collections of molecules are known as chemical spaces. Whereas chemical spaces only contained a few million molecules some years ago, they now hold tens of billions of molecules. In addition, previously “virtual” molecules can now be purchased and...

Read More

Minimizing Risk Within the Pharmaceutical Supply Chain MINIMIZING RISK WITHIN THE PHARMACEUTICAL SUPPLY CHAIN

article

Nov 19, 2019

The U.S. pharmaceutical supply chain is responsible for providing patients safe, secure and timely access to more than 4 billion prescription medicines every year. Sustaining this complex supply chain requires the collaboration between a diverse group of partners, including manufacturers, distributo...

Read More

5 Essentials for a Successful Pharmaceutical Advisory Board Meeting 5 ESSENTIALS FOR A SUCCESSFUL PHARMACEUTICAL ADVISORY BOARD MEETING

article

Nov 19, 2019

It happens all the time across the pharmaceutical industry: you’ve been tasked with understanding customer perceptions better, but your budget and timelines are limited. In these situations, an Advisory Board can be an incredibly valuable tool. Advisory Board meetings help manufacturers seek a...

Read More

The Medicine Plant That Could Have Changed the World. THE MEDICINE PLANT THAT COULD HAVE CHANGED THE WORLD.

article

Nov 18, 2019

Growing up in Tanzania, I knew that fruit trees were useful. Climbing a mango tree to pick a fruit was a common thing to do when I was hungry, even though at times there were unintended consequences. My failure to resist consuming unripened fruit, for example, caused my stomach to hurt. With such in...

Read More

Four predictions on the future of personalised medicine FOUR PREDICTIONS ON THE FUTURE OF PERSONALISED MEDICINE

article

Nov 18, 2019

For as long as there have been people, there have been illness and disease to hobble them. From cancer to the common cold, these nemeses of the human condition aren’t just going to disappear overnight. But medical researchers are still making major headway in how we diagnose and treat differen...

Read More

Welcome to the future of pharma WELCOME TO THE FUTURE OF PHARMA

article

Nov 18, 2019

Innovation in pharma is playing a key role in transforming science, healthcare and even the wider society. From the chance discovery of penicillin to the Human Genome Project – one of the world’s largest collaborative scientific endeavours – we have seen the eradication of devastat...

Read More

What lower prices would mean for drug companies? WHAT LOWER PRICES WOULD MEAN FOR DRUG COMPANIES?

article

Nov 15, 2019

Drug pricing regulations would not decimate the pharmaceutical industry, according to an analysis from health policy researchers at West Health and Johns Hopkins. This throws some cold water on Big Pharma's claims that new drug research and investments would evaporate if the federal government l...

Read More

How big pharma and startups can learn from each other HOW BIG PHARMA AND STARTUPS CAN LEARN FROM EACH OTHER

article

Nov 15, 2019

The way to accelerate benefit to patients changes over time as technology improves and innovation becomes more cutting edge. I’ve always looked for the more cutting-edge projects because, quite frankly, they’re just more intellectually stimulating for me. I like being on the vanguard whe...

Read More

Advertising in newsletters accounts for a quarter of all pharmaceutical marketing ADVERTISING IN NEWSLETTERS ACCOUNTS FOR A QUARTER OF ALL PHARMACEUTICAL MARKETING

article

Nov 14, 2019

Today - with a full year of newsletter coverage - I would like to present excerpts from a new evaluation. All of the following figures relate to the period from January to October 2019. In January of this year, we once again dramatically increased the number of subscribed newsletters - from 100 to 2...

Read More

Does Your Scientific Narrative Resonate in the Pharmaceutical Ecosystem? DOES YOUR SCIENTIFIC NARRATIVE RESONATE IN THE PHARMACEUTICAL ECOSYSTEM?

article

Nov 14, 2019

Pharmaceutical communication is a foundational component of stakeholder engagement and management. In Europe, pharmaceutical communication traditionally focuses solely on interaction with prescribers, while in the US pharma communication also includes direct-to-consumer advertising. Strategic engage...

Read More

Improving medicines adherence with VR IMPROVING MEDICINES ADHERENCE WITH VR

article

Nov 12, 2019

With medicine adherence still a major problem for pharma and healthcare systems, a collaboration between Cognitant Group and Addenbrooke’s Hospital –supported by grants from UCB and Pfizer – is piloting a programme that aims to educate patients through the power of virtual reality ...

Read More

WHY ETHANOL WORKS SO WELL FOR CANNABIS EXTRACTION WHY ETHANOL WORKS SO WELL FOR CANNABIS EXTRACTION

article

Nov 12, 2019

Cannabis comes with a lot of known health benefits to users with little to no side effects, unlike pharmaceutical drugs. Advancement in technology now allows manufacturers to extract various products infused within cannabis such as extracts, concentrates, edibles, etc. The use of ethanol in extracti...

Read More

Could Cannabinoids Be Used To Treat PTSD? COULD CANNABINOIDS BE USED TO TREAT PTSD?

article

Nov 12, 2019

The use of cannabinoids to treat PTSD is becoming a much more common treatment regime. Historically, cannabinoids were difficult to prescribe, as national legislation restricted scientists from studying their therapeutic efficacy. Without this research and with the lack of a product monograph, in th...

Read More

Artificial Intelligence and Machine Learning/Translation in Pharma Language Translation ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING/TRANSLATION IN PHARMA LANGUAGE TRANSLATION

article

Nov 11, 2019

AI, in practice, has a lot of potential and also a lot of limitations. AI is being used to model, extrapolate, and automate tasks throughout the lifecycle of a drug (as it should be). The potential benefits are substantial, both in terms of clinical efficacy and financial savings. The low-hanging fr...

Read More

The Impact of Synthesis Innovation in Drug Discovery THE IMPACT OF SYNTHESIS INNOVATION IN DRUG DISCOVERY

article

Nov 11, 2019

The term "process chemistry" describes the action of "scaling up" reactions – taking small quantities of a chemical compound and synthesizing it on a much greater scale. A process chemist is tasked with developing synthetic routes that are safe, cost-effective and efficient...

Read More

Collaboration Is the X Factor in Making Precision Medicine a Success COLLABORATION IS THE X FACTOR IN MAKING PRECISION MEDICINE A SUCCESS

article

Nov 11, 2019

Last year, the FDA approved 59 new molecular entities for the US market, the highest number ever approved in a single year. A key driver of this record level of approvals is the explosive growth of precision medicine. Since 2015, at least a fifth of all new drug approvals each year have been precisi...

Read More

Intelligent drug discovery: Powered by AI INTELLIGENT DRUG DISCOVERY: POWERED BY AI

article

Nov 08, 2019

Drug discovery is the process of identifying new medicines for treating or curing human diseases. While drug discovery has led to many life-saving and life-enhancing clinical treatments, historically the process has also been long, expensive, and often unsuccessful, with many areas of unmet need sti...

Read More

Virtual pharma – now for real? VIRTUAL PHARMA – NOW FOR REAL?

article

Nov 08, 2019

Over the last decades, the advances in medical science, the growing competition and the demands of the payers have led to permanent changes and adaptations of the pharma business model. Even the biggest companies do not do everything in-house. Instead, the industry has developed partnering as one ke...

Read More

What is Allometric Scaling and How Does it Support Drug Development? WHAT IS ALLOMETRIC SCALING AND HOW DOES IT SUPPORT DRUG DEVELOPMENT?

article

Nov 06, 2019

There are many aspects of drug development that must be understood before a drug can be tested in humans. Nonclinical studies are conducted to understand the safety (i.e., toxicity and safety pharmacology) of drug candidates and to provide critical pharmacokinetic (PK) information, including insight...

Read More

How Key Pharma And Device Executives Are Developing The Next Generation Of Quality Professionals And Leaders HOW KEY PHARMA AND DEVICE EXECUTIVES ARE DEVELOPING THE NEXT GENERATION OF QUALITY PROFESSIONALS AND LEADERS

article

Nov 06, 2019

A team comprising over a dozen chief quality officers (CQOs) representing the medical device, pharmaceutical, animal health, and consumer healthcare industries has pooled its collective passion and wisdom—with input from FDA and other drug and device regulatory agencies—to establish and ...

Read More

First New HIV Strain in 19 Years Identified FIRST NEW HIV STRAIN IN 19 YEARS IDENTIFIED

article

Nov 06, 2019

A research group at the medical devices and health care giant Abbott has discovered a new strain of human immunodeficiency virus, or HIV—the first to be identified in 19 years. Abbott continues to look for potential new HIV strains to ensure that diagnostic tests for blood screening and detect...

Read More

A PHARMA FIRST: FDA-APPROVED APP FOR TREATMENT OF ADDICTION A PHARMA FIRST: FDA-APPROVED APP FOR TREATMENT OF ADDICTION

article

Nov 06, 2019

It’s 2019. If technology is integrated into our daily lives when it comes to work, entertainment, and even social interactions, it shouldn’t come as a surprise that tech is also playing a major role in improving health outcomes. A 2018 study showed that 90% of Americans use digital healt...

Read More

Cancer drug discovery: unravelling the mysteries of halichondrin CANCER DRUG DISCOVERY: UNRAVELLING THE MYSTERIES OF HALICHONDRIN

article

Nov 05, 2019

A joint Harvard-Eisai project has achieved a breakthrough by fully synthesising the highly potent anti-cancer molecule halichondrin, sourced from marine sponges, at scale. It has taken 30 years of research to reach this point, so what has made halichondrin synthesis so difficult, and what are the im...

Read More

Mistakes to Be Avoided When Preparing a Drug Launch MISTAKES TO BE AVOIDED WHEN PREPARING A DRUG LAUNCH

article

Nov 05, 2019

The launch of a new product can be a daunting task. The main reason this happens is that no matter how many times your company has managed to enter new products on the market, chances are that not one initiative entirely resembled another. For better or for worse, there is not a single recipe for su...

Read More

Top 9 Technology Trends That Will Transform “Medicine And Healthcare” In 2020 TOP 9 TECHNOLOGY TRENDS THAT WILL TRANSFORM “MEDICINE AND HEALTHCARE” IN 2020

article

Nov 03, 2019

Healthcare is an industry that is as of now being changed utilizing the most recent technology, so it can address the difficulties it is looking in the 21st century. Technology can help healthcare associations satisfy developing need and proficiently work to convey better patient consideration. Here...

Read More

Next-gen pneumococcal vaccines: a race to the finish or a foregone conclusion? NEXT-GEN PNEUMOCOCCAL VACCINES: A RACE TO THE FINISH OR A FOREGONE CONCLUSION?

article

Nov 01, 2019

Pneumococcal disease, defined as infections caused by the bacterium streptococcus pneumoniae, has long been a source of morbidity and mortality, particularly in infants and the elderly. Importantly, rates of pneumococcal disease have been significantly curtailed, largely in developed regions, due to...

Read More

We Need More than New Antibiotics to Fight Resistance WE NEED MORE THAN NEW ANTIBIOTICS TO FIGHT RESISTANCE

article

Nov 01, 2019

Metabolic disrupters, phages, and other approaches are going to be needed to treat the broadest possible range of patients infected by bacterial pathogens resistant to multiple drugs. In the summer of 1924, Calvin Jr., President Coolidge’s youngest son, developed a blister in his third right t...

Read More

Enforcement Actions Against Sartan Manufacturers ENFORCEMENT ACTIONS AGAINST SARTAN MANUFACTURERS

article

Oct 31, 2019

Health authorities worldwide have overseen the recall of many ‘sartan’ products in the past few years. These recalls began in the US as early as 2013 with a recall of product by Teva Pharmaceuticals. Authorities in the US, EMA, Canada, and Australia, just to name a few, have taken enforc...

Read More

Precision Medicine: How Far We’ve Come PRECISION MEDICINE: HOW FAR WE’VE COME

article

Oct 30, 2019

A decade ago, precision medicine was little more than an idea and a phrase. The term was coined in 2011 by the National Research Council, a non-government agency that advises the government on scientific matters. That year, the NRC issued a report calling for a new “data network” to brin...

Read More

Is semantic technology the AI sweet spot for pharma? IS SEMANTIC TECHNOLOGY THE AI SWEET SPOT FOR PHARMA?

article

Oct 25, 2019

Artificial intelligence (AI) has been trumpeted by many in the pharmaceutical industry as the magic bullet to the issues they face in drug discovery and other research. However, expectations need to be tempered because although it’s easy to get excited by the potential of AI it’s importa...

Read More

Drug Helps Plants Resist Drought: Study DRUG HELPS PLANTS RESIST DROUGHT: STUDY

article

Oct 24, 2019

An engineered small molecule called opabactin that targets the receptor for the hormone abscisic acid (ABA), which plants release in stressful conditions, limited water loss in Arabidopsis, tomato, and wheat, and improved wheat’s tolerance of drought-like conditions in the lab, according to a ...

Read More

Mulesoft: how can API tools speed up drug development? MULESOFT: HOW CAN API TOOLS SPEED UP DRUG DEVELOPMENT?

article

Oct 24, 2019

At its Connect conference in London in early October, MuleSoft brought together its customers and clients across all sectors to discuss how enterprise software, and particularly APIs, can drive efficiencies and contribute to digital transformation. Mulesoft’s David Chao and AstraZeneca’s...

Read More

When the Target Isn’t Really the Target: One Way Cancer Drugs Fall Out of Clinical Trials WHEN THE TARGET ISN’T REALLY THE TARGET: ONE WAY CANCER DRUGS FALL OUT OF CLINICAL TRIALS

article

Oct 24, 2019

Ninety-seven percent of potential new cancer drugs never make it to market, dropping out of clinical trials when they don’t meet measures of safety or efficacy. “Why that is, we don’t really know. But I think that this extremely high failure rate suggests that there are some fundam...

Read More

Channeling the Power of AI into Personalizing Medicine CHANNELING THE POWER OF AI INTO PERSONALIZING MEDICINE

article

Oct 23, 2019

Artificial intelligence has been much discussed of late, but will it really help us solve important problems like how to bring personalized medicine to as many patients as possible? Kate Hilyard, COO of Healx in Cambridge in the UK, believes it can. Getting a drug to clinical trials currently requir...

Read More

Drug Delivery DRUG DELIVERY

article

Oct 23, 2019

A drug’s efficacy can be impacted significantly by the way in which it is delivered. By developing a variety of drug delivery systems (DDSs) it is now possible to better control the pharmacokinetics, pharmacodynamics, toxicity, immunogenicity and efficacy of drugs. By finding the best-suited d...

Read More

Testing Medicines After Brexit: Upholding High QC Standards for Pharmaceuticals TESTING MEDICINES AFTER BREXIT: UPHOLDING HIGH QC STANDARDS FOR PHARMACEUTICALS

article

Oct 22, 2019

Maintaining robust quality control standards is a key priority for any commercial industry – but for pharmaceutical manufacturers, it can literally be a matter of life and death. The medical sector is one of the most stringently regulated in the world, and drugmakers recognize the importance o...

Read More

Do Patients Care About What Your Drug Does? DO PATIENTS CARE ABOUT WHAT YOUR DRUG DOES?

article

Oct 22, 2019

In most randomized pharmaceutical clinical trials, researchers are looking for a statistically significant performance difference between the two courses of therapy. But which is more important to the patient: Statistically significant improvement of a variable, or clinically significant improvement...

Read More

4 ways to talk with vaccine skeptics 4 WAYS TO TALK WITH VACCINE SKEPTICS

article

Oct 21, 2019

Your neighbor is telling you about his new baby. He feels nervous about vaccinating, and says he's considering delaying Lucy's vaccines. Your mother's group is chatting about vaccines. One mother tells the group Jimmy isn't vaccinated, and she's using the Immune-Strengthening Die...

Read More

Why is pharma so bad at sharing clinical trial data? WHY IS PHARMA SO BAD AT SHARING CLINICAL TRIAL DATA?

article

Oct 21, 2019

Since the 90s, the requirements for pharmaceutical companies to register and report results from clinical trials have increased. But analysis published in the BMJ indicates that large pharmaceutical companies could be doing much more when it comes to sharing data. Over the last few decades, pharma c...

Read More

Helping the Pharmaceutical Industry Tackle the Evolving Challenge of Water Quality HELPING THE PHARMACEUTICAL INDUSTRY TACKLE THE EVOLVING CHALLENGE OF WATER QUALITY

article

Oct 18, 2019

Water plays a vital role in a broad range of processes within the pharmaceutical industry, from its use as a reagent and solvent in drug synthesis, to its utilization in formulation development and analytical testing, all the way through to product packaging and labeling. Each application has its ow...

Read More

MEDICAL MARIJUANA AND THE DRUG-FREE WORKPLACE ACT MEDICAL MARIJUANA AND THE DRUG-FREE WORKPLACE ACT

article

Oct 17, 2019

Presently 33 states and the District of Columbia have enacted medical marijuana laws. While some of these laws have been on the books for several years, the impact on employers and company policies are still evolving. This issue has created confusion for federal contractors who are required to compl...

Read More

Could a unique new fungus offer an opioid alternative? COULD A UNIQUE NEW FUNGUS OFFER AN OPIOID ALTERNATIVE?

article

Oct 17, 2019

A new fungus discovered in the estuarine waters of Tasmania could be the unexpected answer to the world's opioid crisis, a current study suggests. Opioids — many of which are prescription painkillers, such as codeine — have created a worldwide health crisis. Many opioids are highly a...

Read More

What Are the Benefits of CBD? WHAT ARE THE BENEFITS OF CBD?

article

Oct 16, 2019

The CBD industry is flourishing, conservatively projected to hit $16 billion in the United States by 2025. Already, the plant extract is being added to cheeseburgers, toothpicks and breath sprays. More than 60 percent of CBD users have taken it for anxiety, according to a survey of 5,000 people, con...

Read More

Maintaining pharmaceutical manufacturing facilities MAINTAINING PHARMACEUTICAL MANUFACTURING FACILITIES

article

Oct 16, 2019

The best ways to keep your facility clean. Pharmaceutical facilities, especially those manufacturing biological products or sterile dosage forms, present considerable cleaning challenges. They must be: designed to be cleanable and maintained, tested for cleanliness, and cleaned thoroughly.

Read More

Which big pharma firms are best at digital? WHICH BIG PHARMA FIRMS ARE BEST AT DIGITAL?

article

Oct 16, 2019

New research by The Worldcom Public Relations Group has ranked pharmaceutical companies according to their usage of digital channels – with Bayer, Pfizer and Boehringer Ingelheim coming out on top. However, the report – called the Digital Health Monitor – also notes that many large...

Read More

DIY drugs: should hospitals make their own medicine? DIY DRUGS: SHOULD HOSPITALS MAKE THEIR OWN MEDICINE?

article

Oct 15, 2019

When a pharmaceutical company raised the price of an essential medicine to unacceptable levels, there was only one thing for pharmacist Marleen Kemper to do: start making it herself. When Kemper was in primary school, she had watched two of her classmates get ill. One had a brain tumour, the other c...

Read More

Five things for pharma marketers to know FIVE THINGS FOR PHARMA MARKETERS TO KNOW

article

Oct 15, 2019

Almost all patients with the vaping-related illness have ended up hospitalized, according to the Centers for Disease Control and Prevention. About half of people with the lung illness end up in the intensive care unit. Twenty-six people have died from the disease, and nearly 1,300 people have gotten...

Read More

Why Follow-On Pharmaceutical Innovations Should Be Eligible For Patent Protection WHY FOLLOW-ON PHARMACEUTICAL INNOVATIONS SHOULD BE ELIGIBLE FOR PATENT PROTECTION

article

Oct 14, 2019

Despite the important role of intellectual property rights in incentivizing innovation, the patenting of pharmaceutical innovation is frequently accused of impeding access to medicine. Criticism of the prevailing patent regime has focused in particular on patents directed towards follow-on pharmaceu...

Read More

Clinical genetics: a part of Pharma’s DNA CLINICAL GENETICS: A PART OF PHARMA’S DNA

article

Oct 14, 2019

Genetic testing has become an increasingly buoyant area for deal making in recent years. While the pharma industry has been experiencing price pressure and low R&D productivity, the recent market ambition for “Precision Medicine”1 has driven interest and growth in clinical genetics a...

Read More

IoT and Drug Adherence: Different Approaches to Connected Solutions IOT AND DRUG ADHERENCE: DIFFERENT APPROACHES TO CONNECTED SOLUTIONS

article

Oct 11, 2019

Sometimes it’s the really small things that make a huge difference to a person’s health. Skipping dosages of prescription medication, for example, has been linked to an array of negative effects. About half of us are guilty of not taking medication correctly, according to figures shared ...

Read More

Method “Matches” Medicines to Their Unique Protein Receptors METHOD “MATCHES” MEDICINES TO THEIR UNIQUE PROTEIN RECEPTORS

article

Oct 10, 2019

A receptor (drug target) can shift from a single subunit to a multi-structure in the presence of a ligand (drug compound) – a process known as "oligomerization". Having a method to determine exactly how different drug compounds target the same receptor is key to understanding why and...

Read More

My pharmacy preregistration training provider wasn MY PHARMACY PREREGISTRATION TRAINING PROVIDER WASN'T UP TO SCRATCH

article

Oct 10, 2019

Pharmacist preregistration trainees are full-time employees, so they need to adjust to a new work environment, study for the registration assessment and juggle their everyday commitments. The preregistration year is stressful, but for hard-working and disciplined individuals, it pays off. And in ret...

Read More

DRUG PRICES KILLING OR DISEASES? DRUG PRICES KILLING OR DISEASES?

article

Oct 10, 2019

The United States is a huge economy and the economies look up to it for inspiration on how to manage the country to yield maximum output from the economy. But the medicines and drugs in the country are something that has always been on the controversial aspects of the country.

Read More

Improving medicines safety as a volunteer pharmacist in Cambodia IMPROVING MEDICINES SAFETY AS A VOLUNTEER PHARMACIST IN CAMBODIA

article

Oct 09, 2019

Cambodia remains one of the poorest countries in the world following the devastating activities of the Khmer Rouge regime of the 1970s, and the standard of its health care is variable. In 2018, I spent two weeks scoping out potential opportunities to improve patient safety at a provincial hospital i...

Read More

Demonstrating drug potency early in cell therapy development DEMONSTRATING DRUG POTENCY EARLY IN CELL THERAPY DEVELOPMENT

article

Oct 07, 2019

With traditional drug development, the FDA typically focuses the majority of its attention on clinical aspects of a drug. With advanced cell and gene therapies, the agency places far more focus on chemistry manufacturing and controls (CMC) much earlier in development. Due in part to the fact that th...

Read More

Shortage of drugs having a serious impact on primary care SHORTAGE OF DRUGS HAVING A SERIOUS IMPACT ON PRIMARY CARE

article

Oct 07, 2019

According to information gleaned from a drug tracker, more than 100 drugs regularly prescribed by GPs are now out of stock, and this is forcing patients to ‘chop and change’ between medicines. The tracker showed that a total of 106 products were unavailable earlier this month, while a fu...

Read More

Critical Strategies For Developing Your Pharma Team CRITICAL STRATEGIES FOR DEVELOPING YOUR PHARMA TEAM

article

Oct 04, 2019

Effective teamwork is crucial for any pharmaceutical company. Whether it's an outstanding sales manager, establishing the company’s brand, or a medical advisor, managing clinical trials by company guidelines, everyone on your team needs to be engaged and focused on the same goals to facili...

Read More

Technology Towards an Efficient Monitoring of Clinical Trials TECHNOLOGY TOWARDS AN EFFICIENT MONITORING OF CLINICAL TRIALS

article

Oct 04, 2019

Clinical Study and Technology are two such genres that are progressing at a rapid rate. The implementation of age old practices does not suffice in any of the scenarios. Clinical trials are common in pharmaceutical industries and they occupy a major part in the approval of a drug. If the process of ...

Read More

Researchers Have Developed Lab-Made THC and CBD RESEARCHERS HAVE DEVELOPED LAB-MADE THC AND CBD

article

Oct 02, 2019

When you smoke, vape, or eat cannabis, you obtain the cannabinoids THC and CBD from any of the thousands of different strains of cannabis plants. Until now, this was really the only way to get those cannabinoids, and trust me, it worked great. But a recent announcement from a man who knows more abou...

Read More

Pharma marketing’s evolving relationship with AI PHARMA MARKETING’S EVOLVING RELATIONSHIP WITH AI

article

Oct 02, 2019

How does artificial intelligence (AI) rank in the minds of pharmaceutical executives? How important is it in their eyes, and how does it compare to other trends? Although the buzz around AI has never been bigger, that’s not to say that every leader in pharma has bought into the hype yet. The D...

Read More

Why is biosimilar adoption slow in the U.S., and can something be done to boost uptake? WHY IS BIOSIMILAR ADOPTION SLOW IN THE U.S., AND CAN SOMETHING BE DONE TO BOOST UPTAKE?

article

Oct 01, 2019

Since the Hatch-Waxman Act of 1984 created an abbreviated regulatory approval pathway for generic pharmaceutical drugs in the U.S., generics have made tremendous strides in bringing down the cost of many medical treatments and even come to dominate some therapeutic areas.

Read More

The market for unborn children: Big Pharma, vaccines and trafficking of aborted fetuses THE MARKET FOR UNBORN CHILDREN: BIG PHARMA, VACCINES AND TRAFFICKING OF ABORTED FETUSES

article

Oct 01, 2019

American family clinics, such as the Planned Parenthood Institute, first help women stop pregnancy . And immediately after, with half-closed doors, a very profitable journey begins. The aborted fetus is dissected in different parts, liver, kidney, thyme, skin, which are sold. A liver can cost up to ...

Read More

What’s been stopping the pharma industry from true RIM transformation? WHAT’S BEEN STOPPING THE PHARMA INDUSTRY FROM TRUE RIM TRANSFORMATION?

article

Sep 30, 2019

The long-hoped for regulatory information management (RIM) transformation has yet to be achieved. As Steve Gens and John Cogan note in their recent paper — The Promise of Enterprise RIM – What’s Slowing the Innovation Potential? – the conversation all-too-often turns to issue...

Read More

95% of people think they could develop dementia with age 95% OF PEOPLE THINK THEY COULD DEVELOP DEMENTIA WITH AGE

article

Sep 30, 2019

A global study on attitudes toward dementia has shown that two-thirds of people believe it to be a natural risk of getting older, which could be limiting the help that people seek. Every 3 seconds, someone develops dementia somewhere in the world. In the United States alone, 5.8 million people are l...

Read More

Measure Patient Experience in Clinical Trials: It’s the right thing to do! MEASURE PATIENT EXPERIENCE IN CLINICAL TRIALS: IT’S THE RIGHT THING TO DO!

article

Sep 27, 2019

Forward-thinking Pharma companies recognize that when evaluating ROI on the patient experience, they need to think beyond finances. PX impacts trust in the brand and reputation in the industry. In the context of the recent Gallup poll on consumer perceptions where the pharma industry rated below ele...

Read More

The 10 latest FDA Orphan Drug Designations for cancer treatments THE 10 LATEST FDA ORPHAN DRUG DESIGNATIONS FOR CANCER TREATMENTS

article

Sep 25, 2019

The FDA grants Orphan Drug Designation to treatments for rare diseases in R&D; here are the 10 most recent for oncologic conditions. The US Food and Drug Administration’s (FDA) Orphan Drug Designation (ODD) denotes medications that are potential promising treatments for rare diseases in th...

Read More

How does a drug for colorectal cancer work? HOW DOES A DRUG FOR COLORECTAL CANCER WORK?

article

Sep 25, 2019

Colorectal cancer is a fatal and common disease, and treatment decisions are often based on what genes have been mutated in the development of the cancer. This means that certain patients with colorectal cancer may benefit from the chemotherapeutic ‘cetuximab’ while other patients may be...

Read More

Could smart pill bottles dispense a solution to drug non-adherence? COULD SMART PILL BOTTLES DISPENSE A SOLUTION TO DRUG NON-ADHERENCE?

article

Sep 25, 2019

To tackle the challenge of medication adherence, particularly in the clinical trial space, UK health tech company Elucid has created a smart pill bottle and mobile app called Pill Connect. Currently in the trial stage, Pharma Tech Focus talks to Elucid’s CEO Dr James Burnstone about how the sy...

Read More

Reviving a Discontinued Drug REVIVING A DISCONTINUED DRUG

article

Sep 24, 2019

Most of the drugs that are taken off the market are removed for reasons other than safety. However, sometimes drug makers choose to remove drugs from the market even if there is no problem with their safety profile. In fact, from 1994 through 2015, 215 drugs were withdrawn from sale, and only 5.1 pe...

Read More

What is DXM? WHAT IS DXM?

article

Sep 24, 2019

A normal dosage of cough syrup has 15 to 30 milligrams of DXM. Most doctors recommend that you do not take more than 30 milligrams over a 24-hour period. It takes between 300 and 1,000 milligrams of DXM to get high. DXM can cause euphoria that ranges from a mild buzz to hallucination or an out-of-bo...

Read More

How a single payer system can help solve the US opioid crisis HOW A SINGLE PAYER SYSTEM CAN HELP SOLVE THE US OPIOID CRISIS

article

Sep 23, 2019

The US now has only a decade to achieve both universal health coverage and to prevent and treat substance abuse under the United Nations’ 2030 Sustainable Development Goals. Katherine Pettus argues that adopting a single-payer public health system is likely to be the only way to achieve these ...

Read More

Immigrants Buying Meds on the Street: A Problem of High Drug Prices and Fears of Deportation IMMIGRANTS BUYING MEDS ON THE STREET: A PROBLEM OF HIGH DRUG PRICES AND FEARS OF DEPORTATION

article

Sep 20, 2019

A lot of media coverage about counterfeit drug threats in the U.S. are spurred by the media relations efforts of organizations funded by pharmaceutical companies, such as the Alliance for Safe Online Pharmacies and Partnership for Safe Medicines. As I see it, their public education efforts conflate ...

Read More

How attractive are Bio-similars for pharma companies? HOW ATTRACTIVE ARE BIO-SIMILARS FOR PHARMA COMPANIES?

article

Sep 20, 2019

Biosimilar therapies are copies of large-molecule, biologic drugs. They differ from generics in that they are not exact copies of the original drug but, rather, a similar molecule that delivers an equivalent clinical outcome to the branded drug. Where small molecule drugs comprise 10s of atoms, biol...

Read More

Zolgensma – more than just the world’s most expensive drug ZOLGENSMA – MORE THAN JUST THE WORLD’S MOST EXPENSIVE DRUG

article

Sep 19, 2019

The US Food and Drug Administration (FDA) recently approved Zolgensma, Novartis’ one-dose gene therapy for the treatment of paediatric patients (less than two years of age) suffering from spinal muscular atrophy (SMA), a rare but life-threatening disease. Zolgensma was acquired by Novartis as ...

Read More

The Enormous Potential of AI for Pharmaceutical THE ENORMOUS POTENTIAL OF AI FOR PHARMACEUTICAL

article

Sep 18, 2019

The adoption of Artificial Intelligence (AI) in research-intensive organizations has essentially seen linear growth in recent years. Pharmaceutical, CRO, university and healthcare organizations are beginning to shift away from theoretical plans to genuine practical applications of machine intelligen...

Read More

Difference Between Opioids and Opiates DIFFERENCE BETWEEN OPIOIDS AND OPIATES

article

Sep 18, 2019

The difference between opioids and opiates is subtle enough that most people use the words interchangeably. After all, they both come from the poppy plant. The biggest difference is that opiates are natural drugs and opioids are synthetic drugs. They both have the same effect on the mind and can cau...

Read More

CBD MARKETING: HIGH MARKS FOR THE NEXT “IT” PRODUCT CBD MARKETING: HIGH MARKS FOR THE NEXT “IT” PRODUCT

article

Sep 18, 2019

CBD and products like it seem to be making an immediate splash in healthcare as of late. But, how has this controversial product gained such rapid success? Across the country more and more companies are popping up selling CBD products ranging from oils to dog treats.

Read More

Building the smartest pharma company in the world BUILDING THE SMARTEST PHARMA COMPANY IN THE WORLD

article

Sep 17, 2019

The Finnish pharmaceutical company Orion Pharma, with help from Reaktor AI, has been on a journey to introduce AI into company operations across the board, to fully utilize all available data, and to build the capability to quickly adapt in an ever- changing world. In other words, their goal is to b...

Read More

Key opinion leaders KEY OPINION LEADERS

article

Sep 16, 2019

Key Opinion Leaders (KOLs) are experts in their field and a respected voice in medical circles. They have an influential quality coveted by companies within the pharmaceutical industry. In this blog, we look at the role of KOLs and the 5 steps to creating an effective partnership. A KOL is typically...

Read More

Why the Medical and Pharmaceutical Industries Need Great Process Piping Systems WHY THE MEDICAL AND PHARMACEUTICAL INDUSTRIES NEED GREAT PROCESS PIPING SYSTEMS

article

Sep 13, 2019

Medical and pharmaceutical manufacturers must adhere to strict sanitation standards and prioritize the safety of the products they create, regardless of production volume or costs. The U.S. Food and Drug Administration (FDA) strictly regulates the design, construction, and operation of medical and p...

Read More

Medical writing - what is it? MEDICAL WRITING - WHAT IS IT?

article

Sep 12, 2019

This blog will give a brief insight into the discipline of medical writing, including the various types of writing and the skills deemed necessary by top medical writing companies. If you require high-quality scientific and medical writing services get in touch with Phil or Anna today - we are more ...

Read More

How a pharmaceutical company’s HIV research became immersive theater HOW A PHARMACEUTICAL COMPANY’S HIV RESEARCH BECAME IMMERSIVE THEATER

article

Sep 09, 2019

Four years ago, when ViiV Healthcare commissioned an ethnographic research study to understand the impact of HIV on black men in Baltimore and Jackson, Mississippi, the pharmaceutical company came away with a set of complex findings. Cultural identity, contextual environment, social structures and l...

Read More

WHAT ARE “COSMECEUTICALS”? WHAT ARE “COSMECEUTICALS”?

article

Sep 03, 2019

The term “cosmeceutical” has become popular in recent years to describe a cosmetic product that claims medicinal benefits. While those in the cosmetic industry use the term to advertise the ingredients and benefits of their products, the FDA does not legally recognize the term. According...

Read More

How our pharmacist-led anticoagulation service saves more than 500 bed days per year HOW OUR PHARMACIST-LED ANTICOAGULATION SERVICE SAVES MORE THAN 500 BED DAYS PER YEAR

article

Aug 28, 2019

Patients who are receiving long-term anticoagulation and are due for surgery, or other invasive procedures, may need to have their anticoagulants stopped temporarily to allow the procedure to be performed safely. In some circumstances, interrupting anticoagulation for a defined period carries minima...

Read More

The advantages of modular over traditional construction for pharmaceutical cleanrooms THE ADVANTAGES OF MODULAR OVER TRADITIONAL CONSTRUCTION FOR PHARMACEUTICAL CLEANROOMS

article

Aug 26, 2019

When constructing a cleanroom, the first decision you’re faced with is whether to opt for traditional (civil) construction over modular panels. There are several important considerations you must factor before making this expensive investment.

Read More

AI Drug Discovery Consortium Joins Forces with NVIDIA AI DRUG DISCOVERY CONSORTIUM JOINS FORCES WITH NVIDIA

article

Aug 08, 2019

Pharmaceutical companies have traditionally kept their data close to the vest because collaborations side effects may include compromising intellectual property and losing the edge over competitors. But sharing data has major perks. The more data a pharma company has at its disposal, the better equi...

Read More

Circuit Denies “Pharma Bro” Martin Shkreli’s Appeal of His Conviction and District Court’s Forfeiture Order CIRCUIT DENIES “PHARMA BRO” MARTIN SHKRELI’S APPEAL OF HIS CONVICTION AND DISTRICT COURT’S FORFEITURE ORDER

article

Jul 22, 2019

On July 18, 2019, the Second Circuit issued a summary order in United States v. Shkreli (Jacobs, Livingston, Bianco) affirming the conviction and sentence of Martin Shkreli after his highly publicized 2017 trial in which he was convicted on two counts of securities fraud and one count of conspiracy ...

Read More

Dark History of Bayer Crop Science DARK HISTORY OF BAYER CROP SCIENCE

article

Jul 21, 2019

Bayer AG is a German chemical and pharmaceutical company that was founded in 1863 by Friedrich Bayerand Johann Wescott in Barmen, Germany. The company is one of the largest producers of aspirin and enjoys selling variety of medications for diabetes, birth control and multivitamins. Although recently...

Read More

China CHINA'S PHARMACEUTICAL MARKET EXPECTED TO BOOM IN COMING YEARS

article

Jul 09, 2019

In a recent panel discussion at the World Economic Forum’s Annual Meeting of the New Champions, held in Dalian, China, ethicists and biotech executives met to discuss a plan for the future of biotech. One of the issues discussed was whether the new big breakthrough in the industry, and the dom...

Read More

Pharmaceutical Packaging Solutions at Uhlman’s Pharmazing Days 2019 PHARMACEUTICAL PACKAGING SOLUTIONS AT UHLMAN’S PHARMAZING DAYS 2019

article

Jul 09, 2019

The 2019 Uhlman’s Pharmazing Days were held in June at Uhlmann’s headquarters in Laupheim, Germany. Over 500 attendees visited, and over 20 exhibition partners showcased pharmaceutical packaging solutions that are integrated with Uhlmann’s systems. Uhlmann Pac-Systeme showed its pa...

Read More

Hot Melt Extrusion in the Pharmaceutical and Food Industries HOT MELT EXTRUSION IN THE PHARMACEUTICAL AND FOOD INDUSTRIES

article

Jul 04, 2019

Hot melt extrusion is a manufacturing technique that was originally established in the early 1930s for use in the plastics and food industries but is now gaining popularity in the pharmaceutical industry as well. Around half of all plastics products are made using hot melt extrusion, which is the pr...

Read More

Booker returns campaign donation from pharmaceutical executive after slamming industry BOOKER RETURNS CAMPAIGN DONATION FROM PHARMACEUTICAL EXECUTIVE AFTER SLAMMING INDUSTRY

article

Jul 02, 2019

The check was from Eagle Pharmaceutical Executive Vice President and Chief Compliance Officer Michael Cordera. The Booker campaign said Cordera listed his occupation as “attorney” for the donation. "[Booker’s] presidential campaign rejects these contributions too, and we caref...

Read More

Six drug-free treatment options for people with cognitive illnesses SIX DRUG-FREE TREATMENT OPTIONS FOR PEOPLE WITH COGNITIVE ILLNESSES

article

Jul 02, 2019

While cures may not currently be possible for many forms of cognitive illnesses, are there ways to treat people without the use of drugs? Some believe it is possible to help manage some of the challenging behaviors and symptoms with a number of drug-free treatment options, including holistic therapi...

Read More

Premier PREMIER'S PROVIDEGX TO LAUNCH INTRAVENOUS NUTRITION DRUG

article

Jul 02, 2019

Premier subsidiary ProvideGx is now supplying cysteine hydrochloride injections to its member providers, the generic-drug division of the group purchasing and consulting organization announced Tuesday. ProvideGx teamed up with the manufacturer Exela Pharma Sciences to deliver the only Food and Drug ...

Read More

Data Pipeline Solution Accelerates Pharmaceutical Research DATA PIPELINE SOLUTION ACCELERATES PHARMACEUTICAL RESEARCH

article

Jun 17, 2019

Pharmaceutical research is data-intensive. It takes tremendous computational power to parse and analyze the requisite giant chunks of data. The cloud delivers that power and helps accelerate research processes and, ultimately, research findings. That’s why one pharmaceutical company was using ...

Read More

VenatoRx Pharmaceuticals to Present at ASM Microbe 2019 VENATORX PHARMACEUTICALS TO PRESENT AT ASM MICROBE 2019

article

Jun 17, 2019

VenatoRx Pharmaceuticals will present ten posters featuring its two development-stage products, cefepime/VNRX-5133 and ceftibuten/VNRX-7145, at ASM Microbe 2019 to be held June 20-24 in San Francisco, CA. VenatoRx will also present an overview if its antibacterial agents portfolio during the Pharma ...

Read More

Bulgarian Pharmaceutical Scientific Society’s journal moves to high-tech ARPHA platform BULGARIAN PHARMACEUTICAL SCIENTIFIC SOCIETY’S JOURNAL MOVES TO HIGH-TECH ARPHA PLATFORM

article

Jun 17, 2019

The established Pharmacia demonstrates a complete makeover in its new issue after signing with scientific publisher and technology provider Pensoft and its signature open-access platform. Launched by the Bulgarian Pharmaceutical Scientific Society in 1954, the open-access, peer-reviewed Pharmacia ha...

Read More

Vertex and Kymera Therapeutics Establish Strategic Collaboration to Discover and Develop Targeted Protein Degradation Medicines for Serious Diseases VERTEX AND KYMERA THERAPEUTICS ESTABLISH STRATEGIC COLLABORATION TO DISCOVER AND DEVELOP TARGETED PROTEIN DEGRADATION MEDICINES FOR SERIOUS DISEASES

article

May 15, 2019

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) and Kymera Therapeutics today announced that the two companies have entered into a four-year strategic research and development collaboration to advance small molecule protein degraders against multiple targets. The collaboration will leverage Kymera...

Read More

Writing competition now open: tell us about the patient who changed your practice WRITING COMPETITION NOW OPEN: TELL US ABOUT THE PATIENT WHO CHANGED YOUR PRACTICE

article

May 07, 2019

It could be about an error you missed, a question you should have asked or an unexpectedly positive outcome to a interaction you will never forget — some patients teach a valuable lesson that endures for an entire professional career. The Pharmaceutical Journal is now accepting entries for its...

Read More

The Emerging Time Of An African Court Of Law THE EMERGING TIME OF AN AFRICAN COURT OF LAW

article

May 06, 2019

Open indictment of genocide and other crimes committed by white collor scientists in collaboration with governmental, medical, military and pharmaceutical establishments against Africans On the 4th of July, what a remarkable date, 2011, it becomes known that more and more African leaders and militar...

Read More

Will pharmacy become a five-year degree? WILL PHARMACY BECOME A FIVE-YEAR DEGREE?

article

Apr 25, 2019

“This is the biggest change in pharmacy education and training since the profession moved in the mid-20th century from the apprenticeship route to become a degree-only profession,” says Marc Donovan, chief pharmacist at Boots. But the proposals from the General Pharmaceutical Council (GP...

Read More

Should pharmacy sell e-cigarettes and encourage people to vape? SHOULD PHARMACY SELL E-CIGARETTES AND ENCOURAGE PEOPLE TO VAPE?

article

Apr 23, 2019

A smoking cessation expert and a pharmacist share their views on whether pharmacies should stock and recommend e-cigarettes to people who want to kick their tobacco habit. It’s been more than ten years since the UK’s public smoking ban pushed cigarette smokers out into the cold in 2007, ...

Read More

PathAI raises $60M for deep learning-based pathology programs PATHAI RAISES $60M FOR DEEP LEARNING-BASED PATHOLOGY PROGRAMS

article

Apr 22, 2019

To help power its artificial intelligence-based pathology services, PathAI has raised $60 million in venture capital funding, with plans to accelerate its R&D into new digital tools and medical devices for the diagnosis and classification of diseases like cancer. In addition, the Boston-based co...

Read More

Percent of Imported Pharmaceutical Ingredients Apparently Unchanged in 20 Years PERCENT OF IMPORTED PHARMACEUTICAL INGREDIENTS APPARENTLY UNCHANGED IN 20 YEARS

article

Apr 19, 2019

According to the FDA, in 2017, 80% of the active pharmaceutical ingredients used to make our medicines are imported. I can’t remember how many times I’ve read (and written) that over the past decade or so. Almost every time I read that particular statistic in the news, it’s often a...

Read More

Five Industries Being Transformed By Artificial Intelligence FIVE INDUSTRIES BEING TRANSFORMED BY ARTIFICIAL INTELLIGENCE

article

Apr 15, 2019

Technology is a transformative force, and there is currently no technology more transformative than AI. Because AI encompasses so many different fields -- from robotics to deep learning to self-driving cars -- it can be hard to quantify the exact impact it has had on the economy and on individual in...

Read More

The UK as a global leader in antimicrobial resistance THE UK AS A GLOBAL LEADER IN ANTIMICROBIAL RESISTANCE

article

Apr 15, 2019

The Government wants the UK to become a leader in the development of products which tackle the global challenge of antimicrobial resistance (AMR). Despite the renewal of the 5-year AMR Strategy, there is no time to wait before driving new antimicrobial innovations into the mainstream. There must be ...

Read More

Pharmaceutical supplier opts for hygienic flowmeter PHARMACEUTICAL SUPPLIER OPTS FOR HYGIENIC FLOWMETER

article

Apr 15, 2019

Specialist process machinery manufacturer, L.B. Bohle, has developed a cleaning system for the pharmaceutical industry using Bürkert's innovative FloWave flowmeter for a compact, hygienic and very accurate process. Incorporating the latest in flow measurement technology has minimised equipm...

Read More

Picking up the pieces of Connecticut PICKING UP THE PIECES OF CONNECTICUT'S ECONOMY

article

Apr 12, 2019

Hop on a Metro-North out of New York City on the New Haven Line. Soon, you’ll hit the pristine picket fences and well-manicured mansions of Fairfield County — the wealthiest metropolitan area in the nation, where finance and industry titans rake in million-dollar incomes and send their c...

Read More

Correction: Importing Prescription Drugs story CORRECTION: IMPORTING PRESCRIPTION DRUGS STORY

article

Apr 12, 2019

TALLAHASSEE, Fla. (AP) — Floridians could eventually gain access to cheaper Canadian prescription drugs under legislation passed Thursday by the state House, a top priority of Republican Gov. Ron DeSantis. The GOP-led House voted 93-22 on Thursday for the measure, which if finalized creates a ...

Read More

Leveraging the Role of AI for More Successful Clinical Trials LEVERAGING THE ROLE OF AI FOR MORE SUCCESSFUL CLINICAL TRIALS

article

Apr 04, 2019

The pharmaceutical industry spends billions on R&D each year. Clinical trials require tremendous amounts of effort, from identifying sites and enrolling patients to overseeing research functions and coordinating trial logistics. Trials often run over budget or are delayed because of a number of ...

Read More



SPOTLIGHT

PAREXEL’s Customer Care Services (CCS) provide your patients, sites, study teams and other healthcare professionals with a single point of contact for clinical, medical, technical and drug supply inquiries. CCS is available 24/7/365 in local language and backed by integrated call center technologies

RESOURCES